Charter

The ISCT Global Government and Public Relations Committee serves the membership and others working in cellular therapy by providing information concerning political and regulatory activities, including new legislation and regulatory guidelines that affect strategic aspects of regenerative medicine including cell-based therapies.

Projects and Objectives

• Establish an active/pro-active structured approach to following relevant legislative and regulatory actions that impact the field of cell and gene therapy worldwide.
• Forge and maintain links with relevant legislators
• Participate in relevant legislative/regulatory activities and meetings
• Craft and disseminate opinion, position and/or advisory statements on relevant issues 
• Monitor relevant legislation 
• Monitor and develop responses to requests for information from the NIH, FDA, EMA, TGA, CFDA and other relevant governmental and regulatory entities globally 
• Communicate Society actions, opinion(s) and position(s) to the ISCT membership through timely Society communiques, relevant articles and summaries in the Telegraft and Cytotherapy as well as at international and regional meetings

Committee Chairs:

Miguel Forte, MD, PhD Chair Zelluna Immunotherapy Oslo, Norway	Bruce Levine, PhD Co-Chair University of Pennsylvania Philadelphia, PA, United States
Committee Members:
Catherine Bollard, MBChB, MD Immediate Past-President Children's National Health System and The George Washington University Washington, DC, United States	John Rasko, AO, MBBS, PhD, FRCPA, FRACP, FAHMS President June 2018 - June 2020 Royal Prince Alfred Hospital Sydney, Australia
Oscar Lee, MD, PhD Asia, Regional Vice-President Elect June 2017 - June 2019 National Yang- Ming University  Taiwan	Ngaire Elwood, PhD Australia & New Zealand, Regional President June 2018 - June 2020 Murdoch Childrens Research Institute Melbourne, Australia
Jaap J. Boelens, MD, PhD Europe, Regional President June 2018 - June 2020 UMC Utrecht Utrecht, Netherlands	Lynn O'Donnell, PhD North America, Regional President June 2018 - June 2020 Ohio State University, James Cancer Hospital Columbus, OH, United States
Patricia Rocco, MD, PhD South & Central America, Regional Vice-President Elect June 2017 - June 2019 Federal University of Rio de Janeiro Rio de Janeiro, Brazil	Karen Nichols, Esq. Chief Regulatory Officer March 2016 - March 2019 Magenta Therapeutics Cambridge, MA, United States
Daniel J. Weiss, MD, PhD Chief Scientific Officer June 2016 - June 2019 University of Vermont Burlington, VT, United States	Queenie Jang, BSc (Pharmacy), MBA Chief Executive Officer  International Society for Cellular Therapy Vancouver, BC, Canada